expert roundtables by Leonard H. Calabrese, DO; Jonathan Kay, MD; and Vibeke Strand, MD, MACR, FACP
Patients with rheumatoid arthritis (RA) are at an increased risk of bone loss due to RA-related systemic inflammation and glucocorticoid-induced os......READ MORE
Options for patients with rheumatoid arthritis who inadequately respond to initial methotrexate (MTX) therapy include triple therapy (ie, MTX, sulf......READ MORE
Rheumatoid arthritis (RA) is associated with an increased risk of thromboembolism characterized by an approximately 2-fold increased risk of pulmon......READ MORE
expert roundtables by Leonard H. Calabrese, DO; Jonathan Kay, MD; and Vibeke Strand, MD, MACR, FACP
Patients with rheumatoid arthritis (RA) have benefited from a reduction in cardiovascular morbidity in recent decades, but their cardiovascular ris......READ MORE
patient care perspectives by Leonard H. Calabrese, DO
Fatigue is a common manifestation of rheumatoid arthritis (RA) that is tremendously important to patients and substantially impairs quality of life......READ MORE
clinical topic updates by Vibeke Strand, MD, MACR, FACP
The interleukin-6 (IL-6) inhibitors have a well-established record in the treatment of rheumatoid arthritis (RA). Available data suggest that there......READ MORE
